by Harvey Mogojwe | Aug 3, 2022
GARDP, Shionogi, and CHAI are working to accelerate access to cefiderocol, an antibiotic for serious Gram-negative bacterial infections, in low- and middle-income countries (LMICs). This RfP aims to solicit competitive bids for a contract to manufacture, obtain WHO...
by Harvey Mogojwe | Aug 1, 2022
August 1, 2022: Unitaid, The Aurum Institute, the Clinton Health Access Initiative (CHAI), and MedAccess today announced two new agreements to lower the price of rifapentine (RPT)-based treatments to prevent tuberculosis in low- and middle-income countries. The...
by Harvey Mogojwe | Jul 27, 2022
July 27, 2022: MedAccess, the Clinton Health Access Initiative (CHAI), and Wondfo today announced an agreement to make Wondfo’s HIV self-test available for US$1. The price is over 30 percent below the current lowest-priced World Health Organization (WHO) prequalified...
by Harvey Mogojwe | Jul 25, 2022
CHAI’s recently released Hepatitis C Market Memo is an update to the previous editions of Hepatitis market reports. It provides critical insights into the market and helps the public and private sectors develop better strategies to provide products and services to...
by Harvey Mogojwe | Jul 25, 2022
We are excited to publish the Hepatitis C Market Memo 2022, a brief covering the latest trends in the hepatitis C diagnostics and treatment markets since the publication of CHAI’s second HCV Market Intelligence Report in August 2021. This memo provides updates on key...
